Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

  • Posts
  • About
  • KOL Interviews
  • Biotech Strategy Blog

links for 2010-01-19

By MaverickNY on January 19, 2010

  • Questioning a Cancer Drug That Costs $30,000 a Month – NYTimes.com
    Allos Therapeutics Folotyn to cost over $120K for treatment of PTCL and GSK's Arzerra to cost $98K for CLL. Yikes!
    (tags: pharmaceuticals drugs cost cancer prices healthcare trends)

Newer postOlder post

Copyright Notice & Terms of Use

© 2006-26 Pharma Strategy Blog
All Rights Reserved.
Without permission you may not copy, display, reproduce or use content in a derivative work or distribute any part of this blog, except as permitted by copyright law. By using this site you accept the Terms of Use.

Protected by Copyscape Plagiarism Software

Terms of Use
Copyright © 2006-26 Pharma Strategy Blog

error: Content is protected !!